ITMCTR1900002365招募中1 期
Diabetes TCM Prevention and Management Based on Accurate Medical Model--Study for the effect of traditional chinese medicine intervention on type 2 diabetes based on clinical pathway management
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- All
入选标准
- •(1) According to the 1999 WHO standard, meet the diagnostic criteria for type 2 diabetes;
- •(2) Aged 18 to 70 years;
- •(3) Sign the patient's informed consent form.
- •(4) Patients can provide detailed contact information, no short-term migration, and willing to cooperate with follow-up.
- •(5) Comply with the Drug TCM Clinical Pathway for Diabetes Mellitus, Traditional Chinese Medicine Diagnosis and Treatment Program for Diabetes Mellitus and Guidelines for Clinical Research of New Drugs in Traditional Chinese Medicine in 2010, the liver and stomach stagnation syndrome and yin deficiency fire certificate Diagnostic criteria for qi and yin deficiency syndrome and yin and yang deficiency syndrome.
- •(6) After screening period (dietary control exercise therapy for 2 weeks), FBG=7.0mmol/l, but <13.9mmol/l, or 2 hours after meal, blood glucose=11.1mmol/l.
排除标准
- •(1) Diabetes complications have been diagnosed;
- •(2) Those with serious complications such as heart, lung, liver, kidney and brain, or those with other serious primary diseases;
- •(3) If the blood pressure is not controlled or controlled, the systolic blood pressure is >160 mmHg or the diastolic blood pressure is >100 mmHg;
- •(4) Patients with diabetic ketoacidosis or severe infection in the past 1 month;
- •(5) Women who are pregnant, breastfeeding, or ready to become pregnant;
- •(6) Those with impaired liver and kidney function (ALT, AST are more than 2 times the upper limit of normal value; serum creatinine is greater than the upper limit of normal value;
- •(7) Patients who are participating in other clinical trials;
- •(8) Psychiatric patients, alcohol and/or psychoactive substances, drug abusers and dependents;
- •(9) According to the judgment of the researcher, other lesions or situations that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in the working environment and unstable living environment, may cause loss of follow-up;
- •(10) Those who are not fully aware of this study, are unwilling to participate, or have poor compliance; those who do not cooperate (can not cooperate with diet control, or do not follow the prescribed medication to affect the efficacy judgment).
研究者
相似试验
招募中
4 期
Effect Study for Qizhijiangtang Capsule on Delaying Early Renal Functional Decline in Type 2 Diabetes Patients with MicroalbuminuriaITMCTR1900002359Guang'anmen Hospital, China Academy of Chinese Medical Sciences
进行中(未招募)
不适用
Religious leaders and diabetes prevention in BangladeshPrevention of diabetesNutritional, Metabolic, EndocrineISRCTN91564707Ministry of Health and Family Welfare824
尚未招募
4 期
Clinical Observation for Yi-Wei Xiao-Yu Granule in Treating Chronic Atrophic Gastritischronic atrophic gastritisITMCTR1900002657Chongqing Hospital of Traditional Chinese Medicine
进行中(未招募)
不适用
Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects with Metabolic Syndrome and High-Normal Blood Pressure. - PHIDIASHypertension, diabetes mellitus.MedDRA version: 6.1Level: SOCClassification code 10007541EUCTR2007-000947-88-ITISTITUTO AUXOLOGICO ITALIANO6,000
已完成
不适用
The control and prevention of type 2 diabetes by the inhibition of adipose tissue inflammation through DiacereiPatients aged 40â€65 years who had type 2 Diabetes for at least 2 years since diagnosis with a glycated haemoglobin (HbA1c) level of 7.5%â€10%type 2 Diabetes who had inadequate glycaemic controlTCTR20200820004/A35
